Other products from "SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 00842768039416 10873440 B4265-37 For coagulation tests and as a rinsing solution for the sample needles of the Sy For coagulation tests and as a rinsing solution for the sample needles of the Sysmex® CA Systems KQJ SYSTEM, FIBRINOGEN DETERMINATION Dade® CA System Buffer
2 00842768028441 10385332 LKPM For use in daily maintenance of the IMMULITE® and IMMULITE® 1000 systems JJQ COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE 1 IMMULITE® Probe Cleaning Kit
3 00842768028427 10385231 L2PWSM For use in the routine operation of the IMMULITE® 2000 and IMMULITE® 2500 Analyzers JJQ COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE IMMULITE 2000/XPi Probe Wash Module
4 00842768017872 10446691 OWZG23 Quantitative determination of fibrinogen in plasma KQJ SYSTEM, FIBRINOGEN DETERMINATION Multifibren® U
5 00842768017865 10446689 OWZG19 Quantitative determination of fibrinogen in plasma KQJ SYSTEM, FIBRINOGEN DETERMINATION Multifibren® U
6 00842768017087 10873532 OPOD05 For quality control of the INNOVANCE® Heparin assay GGN Plasma, coagulation control INNOVANCE Heparin UF Control 2
7 00842768016134 10446085 OQIO19 N/T Protein Control SL/M is a medium level, multi-analyte control for use as acc N/T Protein Control SL/M is a medium level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems JJY Multi-analyte controls, all kinds (assayed) N/T Protein Control SL/M
8 00842768016110 10446089 OQIP19 N/T Protein Control SL/H is a high level, multi-analyte control for use as accur N/T Protein Control SL/H is a high level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems JJY Multi-analyte controls, all kinds (assayed) N/T Protein Control SL/H
9 00842768013065 10446632 OWMG15 Quantitative determination of thrombin/antithrombin III complex (TAT) in human plasma JBQ ANTITHROMBIN III QUANTITATION 2 Enzygnost® TAT micro
10 00842768012945 10446620 OWLD11 Determination of heparin activity in plasma and for the monitoring of heparin therapy KFF ASSAY, HEPARIN 2 Berichrom® Heparin
11 00842768011030 10446415 OTXY13 For the determination of the activity of coagulation factor X in human plasma by For the determination of the activity of coagulation factor X in human plasma by coagulometric methods GJT PLASMA, COAGULATION FACTOR DEFICIENT Coagulation Factor X Deficient Plasma
12 00842768009976 10446316 OSDF13 For the determination of the activity of coagulation factor XI in human plasma b For the determination of the activity of coagulation factor XI in human plasma by coagulometric methods GJT PLASMA, COAGULATION FACTOR DEFICIENT Coagulation Factor XI Deficient Plasma
13 00842768009761 10446295 OSAR19 Quantitative determination of IgA in human serum and plasma on BN Systems CFN METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) 2 N Antisera to Human IgA
14 00842768009747 10446293 OSAR11 Quantitative determination of IgA in human serum and plasma on BN Systems CFN METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) 2 N Antisera to Human IgA
15 00842768008153 10446136 OQUB21 Cleaning solution BN II, BN ProSpec® Systems and BCS® Systems JZW NEPHELOMETER Cleaner SCS
16 00842768008054 10446127 OQTC11 Quantitative determination of soluble transferrin receptor (sTfR) in human serum Quantitative determination of soluble transferrin receptor (sTfR) in human serum and heparinized plasma on BN Systems DDG TRANSFERRIN, ANTIGEN, ANTISERUM, CONTROL N Latex sTfR
17 00842768007477 10461887 OQGP15 LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lu LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants GIR REAGENT, RUSSEL VIPER VENOM LA 1 Screening Reagent
18 00842768007279 10446043 OQDC13 Assayed control for RF ASL and CRP assays on Siemens Systems JJY Multi-analyte controls, all kinds (assayed) N/T Rheumatology Control SL/2
19 00842768006876 10445990 OPCD03 For use as a low level assayed control for the quantitative measurement of low m For use as a low level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin GIZ PLASMA, CONTROL, NORMAL Berichrom® Heparin LMW Control 1
20 00842768006845 10445987 OPCA03 For calibration of the Berichrom Heparin assay for measurement of low molecular For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin JPA SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES Berichrom® Heparin LMW Calibrator
21 00842768006838 10445986 OPBZ03 For use as a high level assayed control for the quantitative measurement of unfr For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin GGC CONTROL, PLASMA, ABNORMAL Berichrom® Heparin UF Control 2
22 00842768006715 10445973 OPAX03 Quantitative determination of homocysteine in human serum and plasma on BN II an Quantitative determination of homocysteine in human serum and plasma on BN II and BN ProSpec® Systems LPS URINARY HOMOCYSTINE (NONQUANTITATIVE) TEST SYSTEM 2 N Latex HCY
23 00842768006388 10445924 KC735 CYSC CON L is an assayed intralaboratory quality control for assessment of preci CYSC CON L is an assayed intralaboratory quality control for assessment of precision and analytical bias in the determination of the CYSC method on the Dimension Vista® System JJY Multi-analyte controls, all kinds (assayed) DImension Vista® Cystatin C Control L (low)
24 00842768006340 10445920 KC716 PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality con PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality control for the assessment of precision and analytical bias on the Dimension Vista® System JJY Multi-analyte controls, all kinds (assayed) DImension Vista® Protein 1 Control M (medium)
25 00842768004056 10445731 B4244-10 For use as control in citrated coagulation systems GGC CONTROL, PLASMA, ABNORMAL Dade® Ci-Trol® Coagulation Control Level 1
26 00842768006173 10445902 K7054 For the quantitative measurement of immunoglobulin E in human serum and plasma ( For the quantitative measurement of immunoglobulin E in human serum and plasma (heparin or EDTA) on the Dimension Vista® System DGC IGE, ANTIGEN, ANTISERUM, CONTROL DImension Vista® Immunoglobulin E Flex® reagent cartridge
27 00842768006135 10445898 K7046 For the quantitative measurement of C-reactive protein in human serum and plasma For the quantitative measurement of C-reactive protein in human serum and plasma on the Dimension Vista® System NQD CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL Dimension Vista hsCRP Flex reagent cartridge
28 00842768006128 10445897 K7044 For the quantitative measurement of total homocysteine in human serum and plasma For the quantitative measurement of total homocysteine in human serum and plasma on the Dimension Vista® System LPS URINARY HOMOCYSTINE (NONQUANTITATIVE) TEST SYSTEM DImension Vista® Homocysteine Flex® reagent cartridge
29 00842768003967 10445722 B4233-60 The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantita The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantitative evaluation of circulating derivatives of cross-linked fibrin degradation products (XL-FDP) in human plasma DAP FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL 2 Dade® DIMERTEST® Latex Assay
30 00842768003929 10445718 B4233-15SY Quantitative determination of fibrinogen in human plasma GFK FIBRINOGEN DETERMINATION STANDARDS AND CONTROLS 2 Dade® Fibrinogen Determination Reagents
31 00842768003905 10445716 B4224-60 Control in heparin assay procedures KFF ASSAY, HEPARIN Dade® Ci-Trol® Heparin Control, High
32 00842768003899 10445715 B4224-50 Control in heparin assay procedures KFF ASSAY, HEPARIN Dade® Ci-Trol® Heparin Control, Low
33 00630414992617 10459382 B4132-1A For differential staining in hematology that gives results similar to a Wright-G For differential staining in hematology that gives results similar to a Wright-Giemsa stain KQC STAINS, HEMATOLOGY 1 Diff-Quik™ Stain Set
34 00630414285054 10873691 OWTI15 Quantitative determination of ADNase B in human serum on BN Systems GTR ANTIDEOXYRIBONUCLEASE, STREPTOCOCCUS SPP. 1 N Latex ADNase B (USA)
35 00630414284996 10873685 OQDC17 Assayed control for RF, ASL and CRP assays on BN Systems JJY Multi-analyte controls, all kinds (assayed) 1 N/T Rheumatology Control SL/2
36 00630414237503 10873663 OPJF05 Assayed accuracy and precision controls in the determination of free light chain Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems. JJY Multi-analyte controls, all kinds (assayed) N FLC CONTROL SL2
37 00630414237480 10873661 OPJE05 Assayed accuracy and precision controls in the determination of free light chain Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems. JJY Multi-analyte controls, all kinds (assayed) N FLC CONTROL SL1
38 00630414023526 10873571 B4233-17SY Quantitative determination of fibrinogen in human plasma GFK FIBRINOGEN DETERMINATION STANDARDS AND CONTROLS 2 Dade® Fibrinogen Determination Reagents
39 00630414002736 10465217 OVLI012 The BN ProSpec® is a system for the quantitative determination of proteins in se The BN ProSpec® is a system for the quantitative determination of proteins in serum, plasma, urine and CSF JZW NEPHELOMETER 1 BN ProSpec® System
40 00842768028410 10385393 LPWS2 For use in the routine operation of the IMMULITE® and IMMULITE® 1000 Analyzers JJQ COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE IMMULITE® Probe Wash Module
41 00842768018534 10445997 OPCS05 Quantitative determination of carbohydrate-deficient transferrin (CDT) in human Quantitative determination of carbohydrate-deficient transferrin (CDT) in human serum on BN II and BN ProSpec® Systems NAO Test,carbohydrate deficient transferrin 1 N Latex CDT Kit
42 00842768014222 10446232 ORHO37 Supplementary Reagent for coagulation tests JPA SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES Calcium Chloride Solution
43 00842768013478 10446673 OWWR17 Determination of the functional activity of antithrombin III (AT III) in human plasma JPE ANTITHROMBIN III, TWO STAGE CLOTTING TIME ASSAY 2 Berichrom® Antithrombin III (A)
44 00842768013461 10446672 OWWR15 Determination of the functional activity of antithrombin III (AT III) in human plasma JPE ANTITHROMBIN III, TWO STAGE CLOTTING TIME ASSAY 2 Berichrom® Antithrombin III (A)
45 00842768012778 10446604 OWHU21 Qualitative detection or semi-quantitative determination of C-reactive protein ( Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum DCN SYSTEM, TEST, C-REACTIVE PROTEIN 2 RapiTex® CRP
46 00842768012686 10446595 OWHG13 Quantitative determination of Ig light chains, type kappa in human serum on BN Systems DFH KAPPA, ANTIGEN, ANTISERUM, CONTROL 2 N Antiserum to Human-Ig/L-chain, K-type
47 00842768012297 10446534 OVLC21 The N Evaporation Cap 2.5ml is part of the BN ProSpec system. JZW NEPHELOMETER N Evaporation Caps for Control Vials (2.5 mL)
48 00842768012174 10446521 OVIC11 The N Predilution Well is used for settings of dilutions of standards, controls and sera. DEW IGG, ANTIGEN, ANTISERUM, CONTROL N Predilution Wells
49 00842768011443 10446458 OUMU15 Supplementary reagent for multiple protein assays on Siemens systems CFN METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) 2 N Supplementary Reagent/Precipitation
50 00842768011085 10446420 OUAX41 Qualitative detection or semi-quantitative determination of C-reactive protein ( Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum DCN SYSTEM, TEST, C-REACTIVE PROTEIN 2 RapiTex® CRP
Other products with the same Product Code "JPA"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 05391521421081 M01000 Destiny MAX Analyzer TCOAG IRELAND LIMITED
2 05391521421029 H01000P Destiny Plus TCOAG IRELAND LIMITED
3 05391521421012 N04000 KC® 4 Delta TCOAG IRELAND LIMITED
4 05391521421005 G05000 KC® 1 Delta TCOAG IRELAND LIMITED
5 04987562433735 BV981798 CS-2500 COMPLETE Automated Blood Coagulation Analyzer CS-2500 SYSMEX CORPORATION
6 04987562425686 BR142626 Automated Blood Coagulation Analyzer CA-620 Automated Blood Coagulation Analyzer CA-600 series CA-620 SYSMEX CORPORATION
7 04987562425426 BY990757 CS-5100 COMPLETE Automated Blood Coagulation Analyzer CS-5100 SYSMEX CORPORATION
8 04987562409471 06372511 CS-2100i COMPLETE Automated Blood Coagulation Analyzer CS-2100i SYSMEX CORPORATION
9 G0561025161 102516 102516 Lupus Anticoagulant Confirmation Reagent BIO/DATA CORPORATION
10 04260160470587 delta System (US/CA) 201001 The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively. ROTEM® TEM INNOVATIONS GMBH
11 04260160470372 sigma 211000 The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. ROTEM® TEM INNOVATIONS GMBH
12 04260160470358 sigma ROTROL P 555202 The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. ROTEM® TEM INNOVATIONS GMBH
13 04260160470341 sigma ROTROL N 555201 The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. ROTEM® TEM INNOVATIONS GMBH
14 04260160470327 sigma complete + hep 555502 The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. ROTEM® TEM INNOVATIONS GMBH
15 04260160470242 ex-tem® 503-05-US The EXTEM assay is a semi-quantitative in vitro diagnostic assay used to monitor The EXTEM assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the extrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). CFT and alpha (Speed of Clot Formation) are complementary parameters and should be used in conjunction with the main parameters Clotting Time (CT) and Clot Firmness (A20/MCF). ROTEM® TEM INNOVATIONS GMBH
16 04260160470112 ROTROL P 503-25-US, 503-25 ROTROL P is a quality control material for monitoring accuracy and precision of ROTROL P is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only. ROTEM® TEM INNOVATIONS GMBH
17 04260160470105 ROTROL N 503-24-US, 503-24 ROTROL N is a quality control material for monitoring accuracy and precision of ROTROL N is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only. ROTEM® TEM INNOVATIONS GMBH
18 04260160470099 star-tem® 20 503-10-US The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve – clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The star-tem® reagent is intended for use as recalcification reagent in the NATEM and INTEM assay on the ROTEM® delta. The corresponding assays are described in the NATEM assay application sheet and in the Instructions for Use of the in-tem® reagent (REF 503-02-US), resp. ROTEM® TEM INNOVATIONS GMBH
19 04260160470082 hep-tem® 503-09-US The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The hep-tem® assay is a semi-quantitative in vitro diagnostic assay used to inactivate heparin in patients receiving unfractionated heparin on the ROTEM® delta. To monitor the coagulation process citrated whole blood specimens are used. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). ROTEM® TEM INNOVATIONS GMBH
20 04260160470075 fib-tem® 503-06-US The FIBTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® The FIBTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® delta Thromboelastometry System to monitor the clot firmness of citrated whole blood specimens after blocking platelet contribution to the clot firmness. fib-tem® is always used in conjunction with ex-tem®. Clotting characteristics are described by the functional parameter Clot Firmness (A20/MCF). ROTEM® TEM INNOVATIONS GMBH
21 04260160470068 ap-tem® 503-04-US The APTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® d The APTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® delta Thromboelastometry System to monitor the clot firmness of citrated whole blood specimens after blocking hyperfibrinolysis by aprotinin. ap-tem® is always used in conjunction with ex-tem®. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). CFT and alpha (Speed of Clot Formation) are complementary parameters and should be used in conjunction with the main parameters Clotting Time (CT) and Clot Firmness (A20/MCF). ROTEM® TEM INNOVATIONS GMBH
22 04260160470044 in-tem® 503-02-US The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The in-tem® assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the intrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). ROTEM® TEM INNOVATIONS GMBH
23 04260160470020 delta System 200100-US The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively. ROTEM® TEM INNOVATIONS GMBH
24 03607450590272 59027 STA R Max® (with cap piercing option) DIAGNOSTICA STAGO
25 03607450590265 59026 STA R Max® DIAGNOSTICA STAGO
26 03607450590135 59013 STA R Max® DIAGNOSTICA STAGO
27 03607450590104 59010 STA R Max® (with cap piercing option) DIAGNOSTICA STAGO
28 03607450589900 58990 STA Compact Max® DIAGNOSTICA STAGO
29 03607450589894 58989 STA Compact Max® (with cap piercing option) DIAGNOSTICA STAGO
30 03607450589795 58979 STA-R Evolution® Expert Series (with cap piercing option) DIAGNOSTICA STAGO
31 03607450589788 58978 STA-R Evolution® Expert Series DIAGNOSTICA STAGO
32 03607450581041 58104 STA Satellite® DIAGNOSTICA STAGO
33 00842768026812 10487098 ORKL19 Standard Human Plasma for the calibration of coagulation and fibrinolysis tests Standard Human Plasma SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
34 00842768024887 10458677 OVKF032 The BFT II Analyzer is a semi-automated device intended for use to determine PT, The BFT II Analyzer is a semi-automated device intended for use to determine PT, APTT and Fibrinogen BFT II Analyzer SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
35 00842768017742 10446684 OWZC39 Washing Solution is used for cleaning the Siemens Healthcare Diagnostics coagula Washing Solution is used for cleaning the Siemens Healthcare Diagnostics coagulation analyzers Washing Solution for Coagulation Analyzers SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
36 00842768014222 10446232 ORHO37 Supplementary Reagent for coagulation tests Calcium Chloride Solution SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
37 00842768012358 10446541 OVMN11 The cuvettes serve coagulation tests as a reaction vessel. Cuvettes for BFT // Analyzer SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
38 00842768012259 10446530 OVKG03 The cuvettes serve coagulation tests as a reaction vessel. BFT II Analyzer Dispo System SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
39 00842768006869 10445989 OPCC03 For calibration of the Berichrom Heparin assay for measurement of unfractionated heparin Berichrom® Heparin UF Calibrator SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
40 00842768006845 10445987 OPCA03 For calibration of the Berichrom Heparin assay for measurement of low molecular For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin Berichrom® Heparin LMW Calibrator SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
41 00817869020311 SC-125, SC-126, H2O Hemotec Whole Blood Control Kit Large ANALYTICAL CONTROL SYSTEMS INC
42 00817869020274 SC-127 SC-127 Whole Blood Control Level III ANALYTICAL CONTROL SYSTEMS INC
43 00817869020267 SC-126 SC-126 Whole Blood Control Level II ANALYTICAL CONTROL SYSTEMS INC
44 00817869020250 SC-125 SC-125 Whole Blood Control Level I ANALYTICAL CONTROL SYSTEMS INC
45 00817869020007 CR-109 CR-109 .02M Calcium Chloride ANALYTICAL CONTROL SYSTEMS INC
46 00673978519173 550-90 CONTROL TEST 550-90 PROFICIENCY 5L NA MEDTRONIC, INC.
47 00613994615633 313-51 DEVICE 313-51 HEPTRAC ELEC QLT CNTRL CEM HEPtrac® MEDTRONIC, INC.
48 B55890013181 900-1318 900-1318 The Reference Plasma Quality Control Kit is for use with the Sonoclot® Analyzer The Reference Plasma Quality Control Kit is for use with the Sonoclot® Analyzer System to verify performance of activated cuvettes. Testing should be performed prior to the use of a new shipment of activated cuvettes and monthly throughout use of the stock. More frequent testing may be required to comply with local, state and federal QC requirements. Reference plasma quality control is important to properly verify proper performance of coagulation test activators. A two level testing approach is used to perform quality control of the activator used in an activated coagulation test. Level I is run with the activator on the reference plasma. Level II is run with the non-activated test on the reference plasma. These two tests confirm the effectiveness of the activator to perform its intended coagulation activation.Each Kit contains:1 vial Reference Plasma Control - 6 ml vial containing a lyophilized preparation of citrated animal plasma, stabilizers and buffer. Contains no human material.1 vial Distilled Water - 6 ml vial containing 5.0 ml laboratory grade distilled water.1 vial 0.02 M Calcium Chloride - 6 ml vial containing 5.0 ml 0.02 M Calcium Chloride.5 plastic 1 ml syringes2 non-activated test cuvettes (blue with clear caps, stir bars, and probes) Sonoclot® Reference Plasma Quality Control Kit SIENCO, INC.
49 B55890013021 900-1302 900-1302 The Reference Viscosity Oil QC test is a simple means of verifying proper operat The Reference Viscosity Oil QC test is a simple means of verifying proper operation of the Sonoclot Analyzer. This test consists of a two point verification of the electromechanical oscillator and also ensures that the heating control is operating accurately. The two verification points are: 1) Probe-In-Air, and 2) Probe-In-Oil. The Probe-In-Air is the response of the electromechanical oscillator to air. The Probe-In-Oil is the response of the electromechanical oscillator to the reference viscosity liquid. Since the viscosity of the reference viscosity fluid is significantly temperature dependent, the Probe-In-Oil test point also verifies the temperature regulation. The QC test should be run each day the Sonoclot Analyzer is used or as required by your institution. Each Reference Viscosity Quality Control Kit contains 24 cuvettes, 24 probes, 1 vial of reference viscosity oil with end cap, and these instructions. These supplies provide 24 QC tests for the analyzer. Sonoclot® Reference Viscosity Oil Quality Control Kit SIENCO, INC.
50 B55880004321 800-0432 800-0432 The SonACT Kit is an in vitro diagnostic reagent for use with the Sonoclot® Coag The SonACT Kit is an in vitro diagnostic reagent for use with the Sonoclot® Coagulation & Platelet Function Analyzer System. The SonACT test is a celite activated whole blood clotting time test. It may also be used with citrated whole blood and plasma. The SonACT Kit is intended for general purpose global hemostasis monitoring including: clot detection, fibrin formation, platelet function, and hyperfibrinolysis. The monitoring information is typically used for anticoagulant management up to high heparin levels (0 to approximately 6 units per ml), hypercoagulable and/or hypocoagulable screening, platelet function assessment, and hyperfibrinolysis screening. When used with the Sonoclot Analyzer System, the SonACT test provides quantitative Onset/ACT and Clot Rate results as well as qualitative and quantitative information on the Sonoclot Signature including: fibrin formation, platelet function, and hyperfibrinolysis.Each kit contains 100 lidded colorless plastic activation cuvettes, 100 probes, and instructions for use. The activation cuvettes contain a controlled amount of celite and a magnetic stir bar. Sonoclot® SonACT Kit SIENCO, INC.